A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma
Clinical trial NCT04884997 · UNKNOWN
Trial details
- NCT number
- NCT04884997
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-07
- Primary completion
- 2024-03-07
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.